healthcare
Quadria-led consortium buys majority stake in Indian hospital chain
Quadria Capital, German development finance institution DEG and Swedfund have acquired a majority stake in Medica Synergie from ICICI Venture.
Blackstone exits Emcure Pharma to Bain
The Blackstone Group will exit its 2006 investment in India’s Emcure Pharmaceuticals to Bain Capital. Financial terms of the deal were not disclosed but it is reportedly worth INR7 billion ($112.8 million)
Carlyle invests in India’s Global Health Private
The Carlyle Group has acquired a minority stake in India’s Global Health Private, owner and operator of Medanta – the Medicity, a super-specialty Medanta hospital in the National Capital Region (NCR) of Delhi. The transaction facilitates the exit...
Anacacia completes two deals in health and education
Australian private equity firm Anacacia Capital has completed two new acquisitions in the health and education sectors: healthcare equipment manufacturer Oxford Group and Careers Training Group - formed as a merger between vocational training firms Selmar...
Actis to sell Sterling Hospitals stake back to promoter
Actis will exit a 2006 investment in India’s Sterling Hospitals chain by selling its 82% shareholding back to the founder, Girish Patel. Financial terms of the deal were not disclosed.
Hony-backed China Consun Pharma targets up to $140m for HK IPO
Consun Pharmaceutical Group, a Chinese medicine retailer backed by Hony Capital, is seeking to raise up to HK$1.09 billion ($140 million) through an IPO in Hong Kong.
India Value Fund Advisors invests $24m in Trivitron Healthcare
Trivitron Healthcare has received INR1.5 billion ($24.5 million) from India Value Fund Advisors (IVFA) for a minority stake in the medical technology company.
Matrix Partners India backs TechMed
Matrix Partners India has invested in TechMed, a hospital lab management (HLM) pathology chain, picking up a significant minority stake. The financial details of the transaction were not disclosed.
Japan’s VC-backed Oncolys Pharma raises $64m in Tokyo IPO
Oncolys Pharma, a VC-backed developer of drugs targeting cancer and serious infectious diseases, saw its stock open at JPY3,500 per share - a 34.6% premium on the offering price - on its first day of trading in Tokyo. This followed a JPY6.6 billion ($64.4...
KKR agrees capital injection
Before agreeing to invest $200 million in India's Gland Pharma, KKR looked at a couple of opportunities in the injectable drugs space in the US and another in India over a period of several years. The PE firm has a long-standing interest in the industry...
Portea Medical raises $7.6m from Accel, Ventureast
Accel Partners and Ventureast have contributed INR480 million ($7.69 million) in Series A funding for Indian home healthcare provider Portea Medical.
Archer consortium scraps bid for NZ's Abano Healthcare
A consortium of investors including Archer Capital has scrapped its bid for New Zealand's Abano Healthcare Group. The group, which also featured Healthcare Industry Limited (HIL) and Steamboat Capital, cited a downgrade in the company's forecast profit...
PE-backed Jintian Pharmaceutical eyes $273m HK IPO
Jintian Pharmaceutical Group, a Chinese pharmaceutical retailer and distributor backed by CVC Capital Partners and SEAVI Advent Private Equity, is seeking to raise as much as $273 million through an IPO in Hong Kong.
KKR to invest $200m in Indian drug maker Gland Pharma
KKR has agreed to buy a minority stake in Gland Pharma, an Indian injectable drugs manufacturer, for approximately $200 million. The investment facilitates the exit of Invascent Capital's Evolvence India Life Sciences Fund (EILSF).
Temasek, Greenwoods back Phoenix Healthcare IPO
Temasek Holdings and Shanghai-based Greenwoods Investment have made a pre-IPO investment in Phoenix Healthcare Group, picking up a 10% stake in the company for RMB165 million ($26.8 million).
Advent adds to China operating partner program
Advent International has appointed healthcare industry veteran Lincoln Chee to its operating partner program in China. He will advise the private equity firm in identifying investment opportunities in the space and in generating value in portfolio companies.
CNEI invests $25.4m in Chinese drug developer
China New Enterprise Investment (CNEI) has acquired a 17% stake in Fudan-Zhangjiang Bio-Pharmaceutical (FDZJ) for $25.4 million, becoming the second-largest shareholder in the Shanghai based bio-pharmaceutical firm.
Darby exits India's Symbiotec Pharmalab, Actis ups stake
Darby Private Equity, the PE arm of Franklin Templeton Investments, has exited its investment in Symbiotec Pharmalab to Actis. Financial terms were not disclosed.
Sequoia leads $16m investment in Cloudnine hospital chain
Sequoia Capital has led INR1 billion ($16.3 million) investment into Bangalore-based infant and maternity care hospital chain Cloudnine. Existing investor Matrix Partners also participated in the round.
KKR invests $89m in Apollo Hospitals' parent
KKR has made an INR5.5 billion ($89.74 million) investment in PCR Investments, the holding company of India’s Apollo Hospitals group.
Qiming invests in traditional Chinese medicine business
Qiming Venture Partners has committed a Series A round of funding to Jun He Tang, a traditional Chinese medicine business. Financial terms were not disclosed.
Tata Capital buys stakes in Tata Sky, Mitra Biotech
Tata Capital’s offshore Tata Opportunities Fund (TOF) has acquired a 5% stake in direct-to-home (DTH) TV provider Tata Sky, while VC fund Tata Capital Innovations has backed cancer care company Mitra Biotech.
Actis invests $48m in Indian pharma company
Actis has invested $48 million for a significant minority stake in Symbiotec Pharmalab, an active pharmaceutical ingredients (API) manufacturer.
Quadrant exits Summerset, buys Estia Health
Quadrant Private Equity has fully exited New Zealand retirement village operator Summerset via the public market, generating an estimated return multiple of more than 3.7x. In the same week, it acquired a majority stake in Australian aged-care operator...